Effects of genipin corneal crosslinking in rabbit corneas

Purpose To evaluate the effect of genipin, a natural crosslinking agent, in rabbit eyes. Setting Department of Ophthalmology, Universidad Nacional de Colombia Centro de Tecnologia Oftalmica, Bogotá, Colombia. Design Experimental study. Methods Ex vivo rabbit eyes (16; 8 rabbits) were treated with ge...

Full description

Saved in:
Bibliographic Details
Published inJournal of cataract and refractive surgery Vol. 42; no. 7; pp. 1073 - 1077
Main Authors Avila, Marcel Y., MD, PhD, Narvaez, Mauricio, MD, Castañeda, Juan P., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose To evaluate the effect of genipin, a natural crosslinking agent, in rabbit eyes. Setting Department of Ophthalmology, Universidad Nacional de Colombia Centro de Tecnologia Oftalmica, Bogotá, Colombia. Design Experimental study. Methods Ex vivo rabbit eyes (16; 8 rabbits) were treated with genipin 1.00%, 0.50%, and 0.25% for 5 minutes with a vacuum device to increase corneal permeability. Penetration was evaluated using Scheimpflug pachymetry (Pentacam). In the in vivo model (20 rabbits; 1 eye treated, 1 eye with vehicle), corneas were crosslinked with genipin as described. Corneal curvature, corneal pachymetry, and intraocular pressure (IOP) assessments as well as slitlamp examinations were performed 0, 7, 30, and 60 days after treatment. Results In the ex vivo model, Scheimpflug pachymetry showed deep penetration in the rabbit corneas with an increase in corneal density and a dose-dependent relationship. Corneal flattening was observed in treated eyes (mean 4.4 diopters ± 0.5 [SD]) compared with the control eyes. Pachymetry and IOP were stable in all evaluations. No eye showed toxicity in the anterior chamber or in the lens. Conclusions Corneal crosslinking induced by genipin produced significant flattening of the cornea with no toxicity in rabbit eyes. This crosslinking could be useful in the treatment of corneal ectasia and in the modification of corneal curvature. Financial Disclosure None of the authors has a financial or proprietary interest in any material or method mentioned.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0886-3350
1873-4502
DOI:10.1016/j.jcrs.2016.04.025